Jump to Main Content
Next-generation molecular diagnosis: single-cell sequencing from bench to bedside
- Zhu, Wanjun, Zhang, Xiao-Yan, Marjani, Sadie L., Zhang, Jialing, Zhang, Wengeng, Wu, Shixiu, Pan, Xinghua
- Cellular and molecular life sciences 2017 v.74 no.5 pp. 869-880
- aneuploidy, biomarkers, chromosome translocation, medicine, neoplasm cells, neoplasms, screening
- Single-cell sequencing (SCS) is a fast-growing, exciting field in genomic medicine. It enables the high-resolution study of cellular heterogeneity, and reveals the molecular basis of complicated systems, which facilitates the identification of new biomarkers for diagnosis and for targeting therapies. It also directly promotes the next generation of genomic medicine because of its ultra-high resolution and sensitivity that allows for the non-invasive and early detection of abnormalities, such as aneuploidy, chromosomal translocation, and single-gene disorders. This review provides an overview of the current progress and prospects for the diagnostic applications of SCS, specifically in pre-implantation genetic diagnosis/screening, non-invasive prenatal diagnosis, and analysis of circulating tumor cells. These analyses will accelerate the early and precise control of germline- or somatic-mutation-based diseases, particularly single-gene disorders, chromosome abnormalities, and cancers.